Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TREMFYA DIN 02566877

Status: Marketed
Holder: JANSSEN INC
Molecule: GUSELKUMAB

Health Canada record

Active ingredient(s)GUSELKUMAB 100 MG
Dosage formSolution
RouteSubcutaneous
SchedulePRESCRIPTION; SCHEDULE D
ClassHuman
ATCL04AC16 GUSELKUMAB
Original market date04-May-2026
Current status date04-May-2026
SourceHealth Canada DPD

Establishment licence of the holder

Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing GUSELKUMAB

DINProductCompanyFormStrengthStatus
02469758TREMFYAJANSSEN INCSolutionGUSELKUMAB 100 MGMarketed
02559137TREMFYAJANSSEN INCSolutionGUSELKUMAB 200 MGApproved
02559145TREMFYAJANSSEN INCSolutionGUSELKUMAB 200 MGMarketed
02570890TREMFYAJANSSEN INCSolutionGUSELKUMAB 45 MGApproved
02559153TREMFYA I.V.JANSSEN INCSolutionGUSELKUMAB 200 MGMarketed
02487314TREMFYA ONE-PRESSJANSSEN INCSolutionGUSELKUMAB 100 MGMarketed
Request a quote for TREMFYA

How to read a Canadian DIN record